Lexaria Bioscience (LEXX) Selling, General & Administrative (2017 - 2026)
Lexaria Bioscience (LEXX) Selling, General & Administrative (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
SG&A (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
17.02 Mn |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
1.32 Mn |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
-37.00 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
2.17 Mn |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
-1.52 Mn |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
217,225.00 |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
493.70 Mn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
-7.36 Mn |
| 10 |
Lexaria Bioscience |
7.17 Mn |
1.65 Mn |
20,000.00 |
996,515.00 |
| Date | Value |
|---|
| Feb 28, 2026 |
996,515.00 |
| Nov 30, 2025 |
902,291.00 |
| Aug 31, 2025 |
980,477.00 |
| May 31, 2025 |
1.21 Mn |
| Feb 28, 2025 |
1.24 Mn |
| Nov 30, 2024 |
918,690.00 |
| Aug 31, 2024 |
1.32 Mn |
| May 31, 2024 |
1.25 Mn |
| Feb 29, 2024 |
567,226.00 |
| Nov 30, 2023 |
711,107.00 |
| Aug 31, 2023 |
644,448.00 |
| May 31, 2023 |
825,177.00 |
| Feb 28, 2023 |
644,514.00 |
| Nov 30, 2022 |
947,870.00 |
| Aug 31, 2022 |
462,260.00 |
| May 31, 2022 |
1.75 Mn |
| Feb 28, 2022 |
1.20 Mn |
| Nov 30, 2021 |
1.55 Mn |
| Aug 31, 2021 |
873,584.00 |
| May 31, 2021 |
2.26 Mn |
